A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy (Q44974978)

7 December 2017

A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy (English)

1 reference

7 December 2017

1 reference

1

Jasmohan S Bajaj

1 reference

7 December 2017

Simon D Taylor-Robinson

14

object named as

Simon D Taylor-Robinson

1 reference

7 December 2017

Patrick M Gillevet

2

1 reference

7 December 2017

Neeral R Patel

3

1 reference

7 December 2017

Vishwadeep Ahluwalia

4

1 reference

7 December 2017

Jason M Ridlon

5

1 reference

7 December 2017

Birgit Kettenmann

6

1 reference

7 December 2017

Christine M Schubert

7

1 reference

7 December 2017

Masoumeh Sikaroodi

8

1 reference

7 December 2017

Douglas M Heuman

9

1 reference

7 December 2017

Mary M E Crossey

10

1 reference

7 December 2017

Debulon E Bell

11

1 reference

7 December 2017

Philip B Hylemon

12

1 reference

7 December 2017

Panos P Fatouros

13

1 reference

7 December 2017

12 April 2012

1 reference

7 December 2017

Metabolic Brain Disease

1 reference

7 December 2017

27

1 reference

7 December 2017

205-215

1 reference

7 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11011-012-9303-0

7 December 2017

0 references

cites work

Review article: the modern management of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Inhibitory control test for the diagnosis of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Hepatic encephalopathy: a central neuroinflammatory disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Characterization of fecal microbial communities in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Prevotella bryantii 25A used as a probiotic in early-lactation dairy cows: effect on ruminal fermentation characteristics, milk production, and milk composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Pathogenetic mechanisms of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Symbiotic gut microbes modulate human metabolic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

MR imaging findings in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Cytoscape: a software environment for integrated models of biomolecular interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Role of ammonia and inflammation in minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Betaine: a key modulator of one-carbon metabolism and homocysteine status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Neuropsychological characterization of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Characterization of inflammatory bowel disease with urinary metabolic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Brain phenylalanine and tyrosine levels and hepatic encephalopathy induced by CCl4 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11011-012-9303-0

Effect of Lactitol and Lactulose Administration on the Fecal Flora in Cirrhotic Patients

21 January 2018

1 reference

12 December 2020

Development of a clinical hepatic encephalopathy staging scale

1 reference

12 December 2020

Subclinical hepatic encephalopathy impairs daily functioning

1 reference

12 December 2020

The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy

1 reference

12 December 2020

Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray

1 reference

12 December 2020

Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model

1 reference

12 December 2020

Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy

1 reference

12 December 2020

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy

1 reference

12 December 2020

Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum

1 reference

12 December 2020

Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.

1 reference

12 December 2020

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

12 December 2020

Linkage of gut microbiome with cognition in hepatic encephalopathy

1 reference

12 December 2020

Normal gut microbiota modulates brain development and behavior

1 reference

12 December 2020

10.1007/S11011-012-9303-0

Identifiers

DOI

1 reference

7 December 2017

1 reference